Diabetes risk reduction diet and colorectal carcinogenesis: a prospective cohort study |
Chengcheng Liu |
The Second Affiliated Hospital, Zhejiang University School of Medicine |
PLCO |
Oct 27, 2022 |
PLCO-1082 |
Integrating genetic susceptibility, blood biomarkers, and traditional factors to develop risk-adapted colonoscopy surveillance strategies |
Chengcheng Liu |
The Second Affiliated Hospital, Zhejiang University School of Medicine |
PLCO |
Oct 27, 2022 |
PLCO-1083 |
Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis |
Ben Armstrong |
Massachusetts Institute of Technology |
PLCO |
Oct 27, 2022 |
PLCO-1080 |
Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women |
Alexandra Schmidt |
University of North Dakota |
PLCO |
Oct 19, 2022 |
PLCO-1078 |
Synthetic generation and tagging of CXR and pathology images |
Jonathan Pearson |
NHS Commissioning Board (NHS England) |
PLCO |
Oct 18, 2022 |
PLCOI-1077 |
Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics |
Graham Chapman |
Case Western Reserve University |
PLCO |
Oct 18, 2022 |
PLCO-1074 |
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) |
Jennifer Ose |
University of Utah |
PLCO |
Oct 18, 2022 |
PLCO-1067 |
Impact of Data Driven Decision Making in Healthcare Analytic |
May Myat |
University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar |
PLCO |
Oct 18, 2022 |
PLCO-1064 |
Mathematical modelling of prostate cancer data |
Taylor deVet |
McMaster University |
PLCO |
Oct 18, 2022 |
PLCO-1073 |
Risk-stratified multi-round PSA screening for prostate cancer incorporating population-based screening reference level and subgroup-specific progression indicators |
Huang Yubei |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Oct 11, 2022 |
PLCO-1072 |
Causal inference with incomplete compliance or outcomes truncated by death |
Aixian Chen |
School of Economics and Statistics, Guangzhou University, Guangzhou, China |
PLCO |
Oct 11, 2022 |
PLCO-1069 |
Integrating multi-omics information to explore disease processes |
Tiantian Sun |
Shandong University |
PLCO |
Oct 11, 2022 |
PLCO-1060 |
Looking for the retrospective link between cigarette habits in men and prostate cancer |
Tamara yaghi |
American international School of riyadh |
PLCO |
Oct 11, 2022 |
PLCO-1071 |
The association of the sulfur microbial diet with colorectal adenoma and recurrent adenoma risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Linglong Peng |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Oct 11, 2022 |
PLCO-1070 |
PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL |
Matejka Rebolj |
Queen Mary University of London |
PLCO |
Oct 11, 2022 |
PLCO-1066 |
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
Sigrid Carlsson |
Memorial Sloan Kettering Cancer Center |
PLCO |
Oct 6, 2022 |
2021-1016 |
Dissecting the risk of MGUS/MM in high-risk participants in the PLCO study |
Irene Ghobrial |
Dana-Farber Cancer Institute |
PLCO |
Oct 6, 2022 |
2021-1015 |
Homologous recombination repair capacity and breast cancer risk: a nested case control study |
Hua Zhao |
Virginia Commonwealth University |
PLCO |
Oct 6, 2022 |
2021-1005 |
Type 2 diabetes prevention diet and the risk of renal cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Linglong Peng |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Sep 28, 2022 |
PLCO-1063 |
A systematic evaluation of dietary and behavioral factors associated with endometrial cancer risk and survival |
Hu Xiaoli |
The First Affiliated Hospital of Wenzhou Medical University |
PLCO |
Sep 28, 2022 |
PLCO-1062 |